Pracinostat - Lite Strategy
Alternative Names: SB-939Latest Information Update: 16 Sep 2025
At a glance
- Originator S*BIO
- Developer Helsinn; MEI Pharma; S*BIO; University of Texas M. D. Anderson Cancer Center
- Class Acrylamides; Amines; Antineoplastics; Hydroxamic acids; Imidazoles; Small molecules
- Mechanism of Action Histone deacetylase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Acute myeloid leukaemia; Cancer; Myelodysplastic syndromes; Myelofibrosis